07 July, 2018

An HIV vaccine which aims to provide immunity against various strains of the virus produced an anti-HIV immune system response in tests on 393 people, finds new multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial in the Lancet.


No comments: